Cardiology update 2nd quarter
This update includes some landmark trials which were published in the last 3 months. Myocardial perfusion cardiovascular magnetic resonance imaging has shown some initial promise in trials, rivaroxaban reduced thromboembolic events in heart failure with coronary artery disease, drug-coated balloons...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Medknow Publications
2019-01-01
|
| Series: | Journal of the Practice of Cardiovascular Sciences |
| Subjects: | |
| Online Access: | http://www.j-pcs.org/article.asp?issn=2395-5414;year=2019;volume=5;issue=2;spage=81;epage=85;aulast=Yadav |
| id |
doaj-fced518c50974ddd83b3b8b74fab5ed5 |
|---|---|
| record_format |
Article |
| spelling |
doaj-fced518c50974ddd83b3b8b74fab5ed52020-11-25T01:52:31ZengWolters Kluwer Medknow PublicationsJournal of the Practice of Cardiovascular Sciences2395-54142454-28302019-01-0152818510.4103/jpcs.jpcs_44_19Cardiology update 2nd quarterSatyavir YadavThis update includes some landmark trials which were published in the last 3 months. Myocardial perfusion cardiovascular magnetic resonance imaging has shown some initial promise in trials, rivaroxaban reduced thromboembolic events in heart failure with coronary artery disease, drug-coated balloons show superiority to bare metal stents in patients with high bleeding risk, and various studies are also published to improve cardiac resynchronization therapy pacemaker response.http://www.j-pcs.org/article.asp?issn=2395-5414;year=2019;volume=5;issue=2;spage=81;epage=85;aulast=Yadavatrial fibrillationcoronary artery diseasepercutaneous coronary intervention |
| collection |
DOAJ |
| language |
English |
| format |
Article |
| sources |
DOAJ |
| author |
Satyavir Yadav |
| spellingShingle |
Satyavir Yadav Cardiology update 2nd quarter Journal of the Practice of Cardiovascular Sciences atrial fibrillation coronary artery disease percutaneous coronary intervention |
| author_facet |
Satyavir Yadav |
| author_sort |
Satyavir Yadav |
| title |
Cardiology update 2nd quarter |
| title_short |
Cardiology update 2nd quarter |
| title_full |
Cardiology update 2nd quarter |
| title_fullStr |
Cardiology update 2nd quarter |
| title_full_unstemmed |
Cardiology update 2nd quarter |
| title_sort |
cardiology update 2nd quarter |
| publisher |
Wolters Kluwer Medknow Publications |
| series |
Journal of the Practice of Cardiovascular Sciences |
| issn |
2395-5414 2454-2830 |
| publishDate |
2019-01-01 |
| description |
This update includes some landmark trials which were published in the last 3 months. Myocardial perfusion cardiovascular magnetic resonance imaging has shown some initial promise in trials, rivaroxaban reduced thromboembolic events in heart failure with coronary artery disease, drug-coated balloons show superiority to bare metal stents in patients with high bleeding risk, and various studies are also published to improve cardiac resynchronization therapy pacemaker response. |
| topic |
atrial fibrillation coronary artery disease percutaneous coronary intervention |
| url |
http://www.j-pcs.org/article.asp?issn=2395-5414;year=2019;volume=5;issue=2;spage=81;epage=85;aulast=Yadav |
| work_keys_str_mv |
AT satyaviryadav cardiologyupdate2ndquarter |
| _version_ |
1724994707179700224 |